Previous Issues

Newsletter Archive

In This Issue

• FDA Names Director for Center for Drug Evaluation and Research (CDER) - Read the full story . . .
• FDA Makes Recommendations on Drug-eluting Stents - Read the full story . . .
• FDA Identifies 25 Drugs and Biologics Requiring Safety Plans - Read the full story . . .
• FDA Approves New Vaccine for Gastroenteritis Caused by Rotavirus - Read the full story . . .
• Orphan Drug Approved for Treatment of Rare Inflammatory Syndromes - Read the full story . . .
• AstraZeneca's Nexium Approved for Use in Children - Read the full story . . .
• FDA Triples Heparin Death Count - Read the full story . . .
• China Puts Drug-Safety Onus on Buyers - Read the full story . . .
• FDA Takes Step Toward Establishing Overseas Presence - Read the full story . . .
• FDA Panel Backs Curbs on Anemia Drugs - Read the full story . . .
• J & J Antibiotic Hits FDA Roadblock - Read the full story . . .
• Study Reports Deadlines May Affect FDA Decisions - Read the full story . . .
• Possible Suicide Link Prompts FDA to Probe Merck Asthma Drug - Read the full story . . .
• Abbott Gets FDA Nod for Glucose Monitor - Read the full story . . .
• FDA Rejects Merck's Cholesterol Drug - Read the full story . . .
• FDA to Require Additional Studies on Cholesterol Drug Licensed by Genzyme - Read the full story . . .
• FDA Orders Merck to Correct Vaccine Plant Faults - Read the full story . . .

• Shire ADHD Drug Approved for Adult Use - Read the full story . . .
• GlaxoSmithKline to buy Sirtris for $720m - Read the full story . . .
• FDA Rejects Genzyme's Myozyme Made at Allston Plant - Read the full story . . .
• EMD Serono Plans $50m Expansion in Billerica - Read the full story . . .
• Rituxan Joins List of Treatments that Fail for Severe Form of MS - Read the full story . . .
• Takeda to Pay Billions to Get Into Biotech with Purchase of Millenium - Read the full story . . .
• Genzyme Recalls Transplant Drug In Further Setback - Read the full story . . .
• Cubist Finds its Cubicin Antibiotic is Tainted - Read the full story . . .
• Disease Foundations Provide Millions to Boost Research - Read the full story . . .
• Clinical Results for Hepatitis C Therapy Boost Vertex - Read the full story . . .
• Swiss Pharma Santhera Plants Roots in Hub - Read the full story . . .
• Tysabri's Liver Warning Expanded to MS Patients - Read the full story . . .
• AstraZeneca's Recentin Fails Lung Cancer Trial - Read the full story . . .
• Alnylam Says RNAi Drug Study Meets Goal - Read the full story . . .
• Novartis Buys Control of Eye-Care Company Alcon for $39 Billion - Read the full story . . .
• Bristol-Myers Job Plans Ahead of Schedule in Devens - Read the full story . . .